Who makes MEOPA and paracetamol?

MEOPA and paracetamol is developed by University Hospital, Toulouse.

What development phase is MEOPA and paracetamol in?

MEOPA and paracetamol is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

MEOPA and paracetamol

University Hospital, Toulouse · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	MEOPA and paracetamol
Also known as	Entonox 170 bar
Sponsor	University Hospital, Toulouse
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children. (NA)
METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX) (PHASE4)
Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MEOPA and paracetamol CI brief — competitive landscape report
MEOPA and paracetamol updates RSS · CI watch RSS
University Hospital, Toulouse portfolio CI